Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Skeletal | 29 | 2024 | 4923 | 2.960 |
Why?
|
Regenerative Medicine | 9 | 2024 | 307 | 2.940 |
Why?
|
Rehabilitation | 4 | 2020 | 129 | 1.830 |
Why?
|
Myoblasts | 8 | 2020 | 231 | 1.450 |
Why?
|
Glucuronidase | 3 | 2021 | 202 | 1.410 |
Why?
|
Aging | 12 | 2023 | 8689 | 1.370 |
Why?
|
Osteoarthritis, Knee | 4 | 2023 | 1241 | 1.300 |
Why?
|
Stem Cells | 10 | 2020 | 3522 | 1.230 |
Why?
|
Regeneration | 16 | 2023 | 1508 | 1.200 |
Why?
|
Arsenic | 6 | 2023 | 358 | 1.000 |
Why?
|
Muscle Development | 7 | 2020 | 259 | 0.980 |
Why?
|
Osteoarthritis | 2 | 2023 | 1060 | 0.960 |
Why?
|
Extracellular Matrix | 7 | 2020 | 1725 | 0.840 |
Why?
|
Complement C4b | 1 | 2023 | 132 | 0.830 |
Why?
|
Muscular Dystrophy, Animal | 3 | 2013 | 88 | 0.810 |
Why?
|
Physical Conditioning, Animal | 3 | 2017 | 365 | 0.810 |
Why?
|
Satellite Cells, Skeletal Muscle | 2 | 2016 | 126 | 0.770 |
Why?
|
Cartilage Diseases | 1 | 2023 | 156 | 0.750 |
Why?
|
Stem Cell Transplantation | 5 | 2021 | 1598 | 0.720 |
Why?
|
Platelet-Rich Plasma | 1 | 2022 | 178 | 0.690 |
Why?
|
Musculoskeletal Diseases | 3 | 2017 | 597 | 0.690 |
Why?
|
Guided Tissue Regeneration | 2 | 2016 | 88 | 0.620 |
Why?
|
Cues | 1 | 2023 | 874 | 0.620 |
Why?
|
Muscle Contraction | 5 | 2023 | 1197 | 0.590 |
Why?
|
Resistance Training | 3 | 2024 | 193 | 0.550 |
Why?
|
Muscular Diseases | 3 | 2023 | 553 | 0.550 |
Why?
|
Biophysics | 1 | 2018 | 380 | 0.550 |
Why?
|
Electric Stimulation Therapy | 2 | 2013 | 626 | 0.540 |
Why?
|
Muscle Fibers, Skeletal | 5 | 2023 | 540 | 0.530 |
Why?
|
Sarcopenia | 1 | 2021 | 372 | 0.520 |
Why?
|
Exercise | 6 | 2024 | 5874 | 0.510 |
Why?
|
Menopause | 1 | 2023 | 1645 | 0.510 |
Why?
|
Cartilage, Articular | 1 | 2023 | 1096 | 0.500 |
Why?
|
Spinal Cord Injuries | 4 | 2013 | 924 | 0.500 |
Why?
|
Periodicals as Topic | 2 | 2024 | 1463 | 0.490 |
Why?
|
Tissue Scaffolds | 4 | 2016 | 934 | 0.490 |
Why?
|
Wheelchairs | 2 | 2005 | 78 | 0.480 |
Why?
|
Neural Conduction | 1 | 2015 | 441 | 0.460 |
Why?
|
Fibroblasts | 4 | 2021 | 4106 | 0.460 |
Why?
|
Myofibrils | 1 | 2014 | 141 | 0.450 |
Why?
|
Models, Animal | 3 | 2017 | 2111 | 0.440 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 869 | 0.430 |
Why?
|
Professional Role | 1 | 2016 | 312 | 0.430 |
Why?
|
Neuromuscular Junction | 2 | 2013 | 403 | 0.420 |
Why?
|
Myoblasts, Skeletal | 1 | 2013 | 73 | 0.420 |
Why?
|
Animals | 41 | 2023 | 168253 | 0.420 |
Why?
|
Collagen Type II | 2 | 2023 | 148 | 0.410 |
Why?
|
Mitochondria | 4 | 2020 | 3624 | 0.390 |
Why?
|
Longevity | 1 | 2019 | 1062 | 0.380 |
Why?
|
Military Medicine | 1 | 2013 | 185 | 0.370 |
Why?
|
Electromyography | 1 | 2015 | 1392 | 0.360 |
Why?
|
Mice | 26 | 2023 | 81402 | 0.330 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2819 | 0.330 |
Why?
|
Muscle Strength | 4 | 2021 | 623 | 0.320 |
Why?
|
Exercise Therapy | 2 | 2014 | 925 | 0.300 |
Why?
|
Mice, Inbred C57BL | 11 | 2021 | 22121 | 0.290 |
Why?
|
Dystrophin | 1 | 2009 | 283 | 0.290 |
Why?
|
Chondrocytes | 2 | 2023 | 792 | 0.290 |
Why?
|
Exosomes | 2 | 2022 | 424 | 0.290 |
Why?
|
Energy Metabolism | 2 | 2018 | 2875 | 0.280 |
Why?
|
NF-kappa B | 1 | 2016 | 2485 | 0.280 |
Why?
|
Wound Healing | 4 | 2017 | 2799 | 0.280 |
Why?
|
Nervous System Diseases | 1 | 2017 | 1654 | 0.270 |
Why?
|
Self-Help Devices | 1 | 2007 | 62 | 0.270 |
Why?
|
Electric Stimulation | 2 | 2023 | 1735 | 0.250 |
Why?
|
Cell Differentiation | 10 | 2023 | 11526 | 0.250 |
Why?
|
Physical Therapy Modalities | 3 | 2021 | 536 | 0.250 |
Why?
|
Isometric Contraction | 1 | 2005 | 150 | 0.240 |
Why?
|
Paraplegia | 1 | 2005 | 162 | 0.230 |
Why?
|
Military Personnel | 3 | 2022 | 1246 | 0.220 |
Why?
|
Muscular Dystrophy, Duchenne | 3 | 2011 | 267 | 0.210 |
Why?
|
Autophagy | 3 | 2022 | 1319 | 0.210 |
Why?
|
Epigenesis, Genetic | 3 | 2023 | 3782 | 0.210 |
Why?
|
United States Department of Veterans Affairs | 1 | 2007 | 923 | 0.190 |
Why?
|
Neural Stem Cells | 2 | 2021 | 888 | 0.190 |
Why?
|
Arm | 1 | 2005 | 590 | 0.190 |
Why?
|
Injections, Intra-Articular | 1 | 2022 | 282 | 0.190 |
Why?
|
Caspases, Initiator | 1 | 2020 | 31 | 0.180 |
Why?
|
Mechanotransduction, Cellular | 2 | 2018 | 530 | 0.180 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2021 | 81 | 0.180 |
Why?
|
Contusions | 2 | 2012 | 79 | 0.180 |
Why?
|
Genomics | 1 | 2016 | 5806 | 0.170 |
Why?
|
Humans | 39 | 2024 | 760437 | 0.170 |
Why?
|
Caspase 1 | 1 | 2020 | 226 | 0.170 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2022 | 1929 | 0.160 |
Why?
|
Cartilage | 1 | 2023 | 806 | 0.160 |
Why?
|
Contracture | 1 | 2021 | 235 | 0.160 |
Why?
|
Chloroquine | 1 | 2020 | 274 | 0.160 |
Why?
|
Vesicle-Associated Membrane Protein 3 | 3 | 2022 | 12 | 0.160 |
Why?
|
Male | 24 | 2024 | 360035 | 0.150 |
Why?
|
MicroRNAs | 2 | 2024 | 3796 | 0.150 |
Why?
|
Cells, Cultured | 4 | 2023 | 18955 | 0.150 |
Why?
|
Torsion, Mechanical | 1 | 2017 | 15 | 0.150 |
Why?
|
Recovery of Function | 2 | 2021 | 2975 | 0.140 |
Why?
|
Mammals | 1 | 2023 | 1132 | 0.140 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18216 | 0.140 |
Why?
|
Forelimb | 1 | 2017 | 116 | 0.140 |
Why?
|
Prescriptions | 2 | 2011 | 386 | 0.140 |
Why?
|
Peripheral Nervous System | 1 | 2017 | 151 | 0.130 |
Why?
|
Certification | 1 | 2020 | 418 | 0.130 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2018 | 3609 | 0.130 |
Why?
|
Estrogens | 1 | 2023 | 1519 | 0.130 |
Why?
|
Dependovirus | 1 | 2021 | 715 | 0.130 |
Why?
|
Signal Transduction | 6 | 2024 | 23397 | 0.130 |
Why?
|
Acyltransferases | 1 | 2017 | 305 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2020 | 802 | 0.120 |
Why?
|
Transcription Factor RelA | 1 | 2016 | 253 | 0.120 |
Why?
|
Torque | 2 | 2005 | 133 | 0.120 |
Why?
|
Resilience, Psychological | 1 | 2022 | 787 | 0.110 |
Why?
|
Myostatin | 3 | 2012 | 128 | 0.110 |
Why?
|
Quadriceps Muscle | 1 | 2014 | 156 | 0.110 |
Why?
|
Mitochondria, Muscle | 1 | 2014 | 172 | 0.110 |
Why?
|
Fibrosis | 3 | 2017 | 2048 | 0.110 |
Why?
|
Mice, Inbred mdx | 1 | 2013 | 88 | 0.110 |
Why?
|
Leg Injuries | 1 | 2014 | 179 | 0.110 |
Why?
|
Bioengineering | 1 | 2013 | 99 | 0.100 |
Why?
|
Veterans | 1 | 2007 | 2642 | 0.100 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11900 | 0.100 |
Why?
|
Female | 18 | 2024 | 391875 | 0.100 |
Why?
|
Lipolysis | 1 | 2013 | 210 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2021 | 4277 | 0.100 |
Why?
|
Multiple Sclerosis | 1 | 2007 | 3220 | 0.100 |
Why?
|
Muscular Atrophy | 1 | 2014 | 329 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1876 | 0.100 |
Why?
|
Central Nervous System Diseases | 1 | 2016 | 520 | 0.100 |
Why?
|
Genetic Vectors | 1 | 2021 | 3392 | 0.090 |
Why?
|
Artificial Limbs | 1 | 2013 | 121 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2018 | 1400 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1117 | 0.090 |
Why?
|
Losartan | 1 | 2012 | 265 | 0.090 |
Why?
|
Reactive Oxygen Species | 2 | 2020 | 2137 | 0.090 |
Why?
|
Environmental Pollutants | 1 | 2020 | 1274 | 0.090 |
Why?
|
Robotics | 1 | 2017 | 819 | 0.090 |
Why?
|
Transduction, Genetic | 2 | 2010 | 901 | 0.090 |
Why?
|
Burns | 1 | 2021 | 1863 | 0.090 |
Why?
|
Electrodes | 1 | 2012 | 615 | 0.080 |
Why?
|
Stem Cell Niche | 1 | 2013 | 345 | 0.080 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3428 | 0.080 |
Why?
|
Suramin | 1 | 2008 | 34 | 0.080 |
Why?
|
beta-Galactosidase | 1 | 2010 | 574 | 0.080 |
Why?
|
Biomedical Research | 1 | 2024 | 3421 | 0.080 |
Why?
|
Hindlimb Suspension | 1 | 2009 | 75 | 0.080 |
Why?
|
Age Factors | 2 | 2021 | 18379 | 0.080 |
Why?
|
Action Potentials | 1 | 2015 | 1830 | 0.080 |
Why?
|
Phosphoproteins | 1 | 2017 | 2444 | 0.070 |
Why?
|
Urinary Bladder | 1 | 2014 | 1150 | 0.070 |
Why?
|
Oxidative Phosphorylation | 2 | 2020 | 497 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5778 | 0.070 |
Why?
|
Mice, SCID | 1 | 2012 | 2625 | 0.070 |
Why?
|
Cell Proliferation | 5 | 2020 | 10425 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2020 | 14397 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2021 | 2875 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2895 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3732 | 0.070 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2022 | 599 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1870 | 0.070 |
Why?
|
Stroke | 2 | 2021 | 9745 | 0.060 |
Why?
|
Diffusion of Innovation | 1 | 2010 | 726 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2468 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1248 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3446 | 0.060 |
Why?
|
Central Nervous System | 1 | 2013 | 1337 | 0.060 |
Why?
|
Glycolysis | 2 | 2020 | 832 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20078 | 0.060 |
Why?
|
DNA Methylation | 1 | 2018 | 4383 | 0.060 |
Why?
|
Proteoglycans | 1 | 2007 | 803 | 0.060 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2009 | 499 | 0.060 |
Why?
|
Oncostatin M | 1 | 2023 | 42 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4240 | 0.060 |
Why?
|
Shoulder Pain | 1 | 2005 | 151 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 613 | 0.060 |
Why?
|
Oxidative Stress | 1 | 2014 | 3108 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2007 | 828 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 2018 | 0.050 |
Why?
|
Shoulder | 1 | 2005 | 299 | 0.050 |
Why?
|
Cell Line | 4 | 2021 | 15598 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.050 |
Why?
|
Kinetics | 1 | 2010 | 6377 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3880 | 0.050 |
Why?
|
Phenotype | 2 | 2023 | 16585 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 29831 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9462 | 0.050 |
Why?
|
Collagen | 1 | 2010 | 2637 | 0.050 |
Why?
|
Forecasting | 1 | 2010 | 2925 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3306 | 0.050 |
Why?
|
Adult | 8 | 2024 | 220781 | 0.050 |
Why?
|
Cell Lineage | 1 | 2010 | 2539 | 0.050 |
Why?
|
Neurosecretory Systems | 1 | 2022 | 223 | 0.050 |
Why?
|
Therapies, Investigational | 1 | 2021 | 111 | 0.040 |
Why?
|
Research | 1 | 2009 | 1977 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2007 | 1959 | 0.040 |
Why?
|
Muscle Cells | 1 | 2020 | 194 | 0.040 |
Why?
|
Follistatin | 2 | 2012 | 137 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2014 | 4443 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14565 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3685 | 0.040 |
Why?
|
Carbonic Anhydrases | 1 | 1999 | 108 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3486 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 867 | 0.040 |
Why?
|
Acids | 1 | 2018 | 125 | 0.040 |
Why?
|
Range of Motion, Articular | 1 | 2005 | 1585 | 0.040 |
Why?
|
Shoulder Joint | 1 | 2005 | 739 | 0.040 |
Why?
|
Cell Movement | 1 | 2010 | 5198 | 0.040 |
Why?
|
Young Adult | 4 | 2024 | 59068 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2018 | 293 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12121 | 0.040 |
Why?
|
Extracellular Space | 1 | 2018 | 563 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2022 | 997 | 0.030 |
Why?
|
Rats | 3 | 2021 | 23712 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1075 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2691 | 0.030 |
Why?
|
Explosive Agents | 1 | 2014 | 26 | 0.030 |
Why?
|
Biomimetic Materials | 1 | 2016 | 172 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9443 | 0.030 |
Why?
|
Tensile Strength | 1 | 2014 | 330 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2633 | 0.030 |
Why?
|
Receptor, Endothelin A | 1 | 2013 | 56 | 0.030 |
Why?
|
Cell Death | 1 | 2018 | 1664 | 0.030 |
Why?
|
Afghan Campaign 2001- | 1 | 2014 | 298 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2020 | 1339 | 0.030 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2014 | 225 | 0.030 |
Why?
|
Rabbits | 1 | 2018 | 4780 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1859 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2018 | 1301 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2014 | 413 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2020 | 2453 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2014 | 1045 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4355 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10538 | 0.020 |
Why?
|
Exercise Test | 1 | 2017 | 2127 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1880 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8311 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2020 | 1271 | 0.020 |
Why?
|
Weight-Bearing | 1 | 2011 | 531 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3510 | 0.020 |
Why?
|
Postoperative Care | 1 | 2014 | 1471 | 0.020 |
Why?
|
Decorin | 1 | 2007 | 38 | 0.020 |
Why?
|
Motor Activity | 1 | 2017 | 2710 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9410 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7377 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 554 | 0.020 |
Why?
|
Middle Aged | 3 | 2007 | 220382 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2005 | 22097 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4567 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 6973 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2007 | 671 | 0.020 |
Why?
|
Preoperative Care | 1 | 2014 | 2242 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7849 | 0.020 |
Why?
|
Hippocampus | 1 | 2017 | 3755 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9468 | 0.010 |
Why?
|
Swine | 1 | 2014 | 5915 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10746 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8522 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 12785 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3800 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2007 | 58859 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2911 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10759 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8623 | 0.010 |
Why?
|
Hexosephosphates | 1 | 1999 | 26 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54339 | 0.010 |
Why?
|
United States | 1 | 2007 | 72202 | 0.010 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 1999 | 91 | 0.010 |
Why?
|
Muscle Fatigue | 1 | 1999 | 95 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2007 | 80430 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6525 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27060 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11070 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1999 | 1844 | 0.010 |
Why?
|
Aged | 1 | 2007 | 168840 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 88196 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1999 | 2676 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23953 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39078 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 39947 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 64591 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13616 | 0.000 |
Why?
|